Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.21.1
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net Sales $ 3,290 $ 2,860
Cost of Sales 3,348 3,020
Gross loss (58) (160)
Operating Expenses    
Sales and marketing 368 539
Research and development 490 451
General and administrative 982 1,170
Total operating expenses 1,840 2,160
Loss from operations (1,898) (2,320)
Other income (expenses)    
Interest expense and finance costs (16) (21)
Other income (expense), net 11 2
Total other income (expenses), net (5) (19)
Loss before income taxes (1,903) (2,339)
Income tax benefit    
Current 1,483
Deferred 655
Total income tax benefit 2,138
Net loss $ (1,903) $ (201)
Net loss per share - basic and diluted $ (0.15) $ (0.02)
Weighted average shares outstanding, basic and diluted 12,513,625 10,125,681